CYB5A

Across TCGA pan-cancer cohorts, CYB5A Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated CYB5A data layer compared with 20 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher CYB5A Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CYB5A expression acts as an unfavorable survival marker.

SKCM are the cancer types where CYB5A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Median	All	0.245	0.781	.008	17	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

CYB5A–SKCM (OS)

Open the SKCM breakdown →